plate of grilled chicken and vegetables

Can a Keto Diet Increase Survival in Patients with Glioblastoma?

One man in the United Kingdom is doing the highly improbable - fighting off the deadly glioblastoma multiforme (GBM) by adopting a rigorous ketogenic (keto) diet. The case study was published in Frontiers in...

Journal Reading List

Multiple Myeloma Knowledge Hub

Nurse talking and doing a emotional support to a female senior patient at hospital

Supporting Bone Health in Patients Receiving Stem Cell Transplant

New guidelines from the International Osteoporosis Foundation (IOF) address management of osteoporosis, fracture risk, and overall bone health among patients receiving autologous hematopoietic cell...
FDA approved stamp

Melflufen Combination Approved for Heavily Pretreated Multiple Myeloma

On March 1, the U.S. Food and Drug Administration (FDA) granted accelerated approval to melphalan flufenamide (melflufen) in combination with dexamethasone for the treatment...

KarMMA: BCMA CAR-T Spurs Lasting Remission in Relapsed/Refractory MM

The latest updates from the KarMMA trial, published in The New England Journal of Medicine, showed that treatment with idecabtagene vicleucel (ide-cel) for relapsed/refractory...

Dr. Hari Discusses Upfront Autologous Transplantation for Multiple Myeloma

Parameswaran Hari, MD, Chief of Hematology/Oncology at the Medical College of Wisconsin, spoke with DocWire News about how new therapeutic agents are changing the...

Double ASCT in MM Does Not Increase Survival Compared to Single ASCT

Patients with multiple myeloma (MM) who underwent double autologous stem cell transplantation (ASCT) did not have better overall survival (OS) and progression-free survival (PFS)...
IV bag

POLLUX and CASTOR: Daratumumab Combinations for MM Prolong MRD-Negativity

Therapeutic regimens for multiple myeloma (MM) that use a combination of the anti-CD38 monoclonal antibody daratumumab induce higher rates of sustained minimal residual disease...
Prescription white pills

Real-World Efficacy of All-Oral Triplet Regimen for Myeloma

In an analysis of real-world data, the all-oral triplet regimen of ixazomib, lenalidomide, and dexamethasone (IRD) for the treatment of multiple myeloma (MM) was...
Prognostic Value of Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

Low One-Year Adherence to Lenalidomide in Multiple Myeloma

Real-world data from a single institution showed concerningly low levels of long-term adherence to lenalidomide therapy for multiple myeloma (MM). For this study, researchers sought...